chemotherapy with gemcitabine and oxaliplatin; small molecure TKI lenvatinib; immune-checkpoint inhibitor toripalimab.: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

4

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Gall Bladder Cancer	1
Hypertension	1
Intrahepatic Cholangiocarcinoma (Icc)	1
Lung cancer	1

Recruiting trials involving chemotherapy with gemcitabine and oxaliplatin; small molecure TKI lenvatinib; immune-checkpoint inhibitor toripalimab.

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
NCT06852287 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve chemotherapy with gemcitabine and oxaliplatin; small molecure TKI lenvatinib; immune-checkpoint inhibitor toripalimab.?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.